Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

55.83
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
25.92
Today|||52-Week Range
55.85
+66.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues47.7M160.9M88.3M102.8M
 
 
 
 
 
Depreciation And Amortization352.0K639.0K1.7M2.1M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses28.4M36.1M55.8M76.1M
 
 
 
 
 
Research And Development18.7M23.2M40.5M57.5M
 
 
 
 
 
Total Operating Expenses28.8M36.7M57.4M78.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income19.0M124.1M30.8M24.6M
 
 
 
 
 
Extraordinary Credit--347.0K29.0K0.00
 
 
 
Extraordinary Charge-166.0K0.000.00-159.0K
 
 
 
Interest Expense On Debt18.0K8.0K45.0K40.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income19.3M125.5M32.6M26.9M
 
 
 
 
 
Income Taxes-15.2M-46.5M-10.9M-9.2M
 
 
 
 
 
Net Income34.4M79.0M21.7M17.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.4M18.7M18.9M19.1M
 
 
 
 
 
Shares To Calculate EPS Diluted19.2M19.3M19.2M19.4M
 
 
 
 
 
 
Earnings Per ShareEPS$1.80$4.09$1.13$0.91
 
 
 
 
 
EPS Diluted$1.80$4.09$1.13$0.91